Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 7,109

Document Document Title
WO/2018/078657A1
The present invention discloses a simple, economic, consistent, commercially viable and industrially applicable process for preparation of Glipizide in high yield and highly pure Glipizide having purity more than 95%, preferably more tha...  
WO/2016/201354A1
Described are compositions and methods for treating cancer. Some methods comprise the administration of an effective amount of at least one inhibitor of tryptophan 2, 3-dioxygenase (TDO) and/or indoleamine 2, 3-dioxygenase (IDO), optiona...  
WO/2015/111943A1
The present invention relates to an organic compound, and an organic electroluminescent device containing the same. The luminescence efficiency, driving voltage, lifetime and the like of an organic electroluminescent device can be improv...  
WO/2015/050989A3
The compounds and salts of the present invention inhibit kinases, especially the anaplastic lymphoma kinase (ALK) and the HGF receptor tyrosine kinase (RTK) c-Met, and are useful for treating or ameliorating abnormal cell proliferative d...  
WO/2013/072896A1
The present invention is related to variants of mycolactones of formula (I), processes for the preparation thereof, pharmaceutical compositions thereof and their use in modulating inflammation, immunity and pain. Y-O-W (I), wherein Y and...  
WO/2012/174564A1
Methods of preparing hetero ionic complexes, and ionic liquids from bisulfate salts of heteroatomic compounds using dialkylcarbonates as a primary quaternizing reactant are disclosed. Also disclosed are methods of making electrochemical ...  
WO/2010/063069A1
The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compoun...  
WO/2009/089482A1
Substituted pyridoindoles for incorporation in pharmaceutical compositions employed in the treatment of various diseases correspond to formula (I) wherein R1 is H or optionally substituted alkyl; R2, R3, R4 are each independently selecte...  
WO/2008/122115A1
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula compounds of the Formula (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable ...  
WO2005030712A8
A series of compounds represented by the structural formulas and pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and thei...  
WO/2007/138307A3
A sulfur-containing acid removal process for deacidifying a crude oil and/or crude oil distillate containing sulfur-containing acids comprising the steps of: (a) contacting the crude oil and/or crude oil distillate containing sulfur-cont...  
WO/2007/138307A2
A sulfur-containing acid removal process for deacidifying a crude oil and/or crude oil distillate containing sulfur-containing acids comprising the steps of: (a) contacting the crude oil and/or crude oil distillate containing sulfur-cont...  
WO/2007/134958A1
There are presented compounds of the formula (I) wherein R1, R2, R3 and R4 are as defined in the description and claims, or a pharmaceutically acceptable salt thereof, which are active adenosine A2B receptor antagonists and useful in the...  
WO/2007/108742A1
The present invention relates to new compounds of formula I, or salts, solvates or solvated salts thereof, wherein Q, R1, R2, R3, R4 and n are defined as in claim 1, processes for their preparation and to new intermediates used in the pr...  
WO/2007/087684A1
The present invention relates generally to substituted benzofurans, benzothiophenes, and indoles and their use as tubulin polymerisation inhibitors.  
WO2003072033A3
The present invention provides common ligand mimics that act as common ligands for a receptor family. The present invention also provides bi-ligands containing these common ligand mimics. Bi-ligands of the invention provide enhanced affi...  
WO/2006/073967A1
Compounds useful as prodrugs of potassium channel inhibitor compounds, in particular as prodrugs of Kv1.5 channel inhibitors.  
WO/2005/116020A1
Objects of the present invention are the compounds of formula (I), their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them...  
WO2005058916A3
The present invention relates to organometallic transition metal compounds of formula (I) where M<1>, X, n, Z, R<1>-R<8> and A are as defined in the claims, biscyclopentadienyl ligand systems having such a substitution pattern, catalyst ...  
WO/2005/100370A1
The present invention refers to new compounds derived from artesunate salts with quinolines represented by the general formula (I) where X is represented by the general formula (II) and Y is represented by the general formula (III) depen...  
WO2004072031A8
Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.  
WO2005046688A3
A method of treating a therapeutic condition comprising administering to a mammal in need of such treatment an effective amount of at least one compound of the formulas (I) and (II) or a pharmaceutically acceptable isomer, salt, solvate ...  
WO2004054991A8
The invention relates to salts consisting of bis(trifluoromethyl)imide anions and saturated, or partially or fully unsaturated heterocyclic cations, to a method for their production and to their use in ionic liquids.  
WO/2005/075422A1
The invention relates to a process for the manufacture of an 1,2,4-triazol-1-yl compound of the formula [A], or a salt thereof, wherein each of R3 and R4 is hydrogen or lower alkyl, said process comprising reacting a hydrazine compound o...  
WO/2005/070896A1
The invention relates to a method for producing ionic liquids consisting first in reacting an ionic liquid with an alkylate, a hydrogencarbonate, a carbonate, a carboxylate or a hydroxide and, afterwards in neutralising with an acid. The...  
WO/2005/070923A1
A crystalline polymorph of a bislulfate salt of a thrombin receptor antagonist compound, which exhibits a powder x-ray diffraction profile substantially the same as that shown in FIG. 1, or which exhibits a differential scanning calorimt...  
WO/2005/068404A1
The invention relates to a method for the distillation of ionic liquids. According to said method, in one step the pressure is set to a value below the ambient pressure and in a subsequent step, the ionic liquid is heated to a temperatur...  
WO2002096905A8
The present invention provides a compound of formula I: or a pharmaceutically acceptable derivative thereof. These compounds are inhibitors of protein kinases, particularly inhibitors of GSK3, Aurora2, and Syk mammalian protein kinases. ...  
WO2004093828A3
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures have utility over a wide range of fields, ...  
WO/2005/058916A2
The present invention relates to organometallic transition metal compounds of formula (I) where M1, X, n, Z, R1-R8 and A are as defined in the claims, biscyclopentadienyl ligand systems having such a substitution pattern, catalyst system...  
WO2005040121A3
The present invention relates to compounds of formula (I), that are novel VR1 antagonists useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.  
WO/2005/046688A2
A method of treating a therapeutic condition comprising administering to a mammal in need of such treatment an effective amount of at least one compound of the formulas (I) and (II) or a pharmaceutically acceptable isomer, salt, solvate ...  
WO/2005/040121A2
The present invention relates to compounds of formula (I), that are novel VR1 antagonists useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity.  
WO/2005/037954A1
Disclosed is a compound represented by formula 1: wherein each of A, X, Y, Y’, and Y’’ has the same meaning as described herein. When used in an organic light emitting device, the compound represented by formula 1 has at least one ...  
WO/2005/030712A2
A series of compounds represented by the structural formulas and pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and thei...  
WO/2005/030712A3
A series of compounds represented by the structural formulas and pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and thei...  
WO/2005/023235A1
The invention aims at providing novel low-molecular compounds which have G-CSF-like activities and can substitute for G-CSF preparations. The invention relates to G-CSF-like agonists containing as the active ingredient benzyl alcohol der...  
WO/2005/019183A1
Disclosed is a method for producing purified 1,3-substituted imidazolium salts of general formula (I) by reacting a 1,3-substituted imidazolium salt of general formula (II) with a strong base at a temperature ranging between 20 and 250 ...  
WO/2005/016890A1
Compounds of Formula (I), are novel VR1 antagonists that are useful in treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity.  
WO/2005/014583A1
An azole derivative of formula (I) having a fluorovinyl moiety or a pharmaceutically acceptable salt thereof is superior to the conventional antifungal drugs in antifungal activity against a wide spectrum of pathogenic fungi, and has adv...  
WO2004083208A8
The present invention relates to novel substituted piperidine and piperazine derivatives as melanocortin-4 receptor (MC-4R) modulators. MC-4R agonists of the invention can be used for the treatment of disorders and diseases such as obesi...  
WO2004064764A3
This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compou...  
WO2004071390A3
The present invention is related to piperazine -2-carboxamide derivatives of formula (I) for the treatment and/or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery. Wherein A, X...  
WO2003063797A8  
WO2004072031A3
Compounds of Formula (I): or pharmaceutically acceptable salts thereof, are useful in the prophylactic and therapeutic treatment of hyperglycemia and diabetes.  
WO2004062609A3
Compounds containing the pyrimidine nucleus and their use to treat diseases and conditions related to inappropriate Interleukin-8 receptor activity are disclosed. The compounds are of the formula (I). In these compounds, Q is preferably ...  
WO/2004/093828A2
Conformationally constrained compounds that mimic the secondary structure of reverse-turn regions of biologically active peptides and proteins are disclosed. Such reverse-turn mimetic structures have utility over a wide range of fields, ...  
WO2003077847A3  
WO2004000826A8
A compound represented by the following formula (I) is reacted with a trimethyloxosulfonium salt, etc. in the presence of a base to obtain a compound (II). The compound (II) is converted into a compound (IV). The compound (IV) is reacted...  
WO/2004/089914A1
The invention relates to benzenesulphonamide derivatives of formula (I), methods and intermediate products for production thereof and use of said compounds, or means comprising said compounds for the control of undesired plants and for t...  

Matches 1 - 50 out of 7,109